Renhe Pharmacy Co.,Ltd (SHE:000650)
5.09
+0.05 (0.99%)
Oct 23, 2026, 3:04 PM CST
Renhe Pharmacy Co.,Ltd Revenue
Renhe Pharmacy Co.,Ltd had revenue of 961.72M CNY in the quarter ending June 30, 2026, a decrease of -2.80%. This brings the company's total for the last twelve months to 3.65B, down -0.91% year-over-year. In the year 2025, Renhe Pharmacy Co.,Ltd had annual revenue of 3.54B, down -13.21%. That makes Renhe Pharmacy Co.,Ltd the 10,748th largest company in the world by revenue and 1,778th in China.
Revenue (ttm)
3.65B
Revenue Growth
-0.91%
P/S Ratio
1.91
Revenue / Employee
741.88K
Employees
4,923
Market Cap
7.04B
Revenue by Segment
- Medicine (including health products) 3.45B 97.6%
- Unallocated Others 85.52M 2.4%
Fiscal year ended Dec 31, 2025 See the full Renhe Pharmacy Co.,Ltd breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.54B | -538.47M | -13.21% |
| Dec 31, 2024 | 4.07B | -957.25M | -19.02% |
| Dec 31, 2023 | 5.03B | -121.07M | -2.35% |
| Jan 1, 2023 | 5.15B | 217.46M | 4.41% |
| Jan 1, 2022 | 4.94B | 657.96M | 15.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Beijing Foyou Pharma CO.,LTD | 3.58B |
| Jiangsu Kanion Pharmaceutical | 3.31B |
| Zhejiang Tianyu Pharmaceutical | 3.30B |
| Jiuzhitang | 2.60B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.04B |
| Guilin Sanjin Pharmaceutical | 2.02B |
| Guangxi Wuzhou Zhongheng Group | 1.44B |
| Zhejiang Garden Biopharmaceutical | 1.27B |